Aeternum exists to curate and support research shaping biological optimization.
Our peptides are shaped by the research culture of the US West Coast and sourced with precision from Great Britain.
We say what the science shows and nothing more. No overstating, no commercial pressure on our claims.
Every compound, every process, every communication held to the same exacting standard.
Everything we do connects back to one thing: advancing the science of human longevity.
We're invested in what the latest bio-optimization and cellular health research is uncovering.
TWe are open about where our compounds come from, how they are handled, and what the research behind them demonstrates.
Honest communication isn't something we reserve for certain clients or certain questions; it runs through every stage of the process—from sourcing to delivery to the science we publish on our site.
Precision, transparency, and research integrity at every stage.
Every vial labeled accurately: compound, concentration, batch.
No substitutions, ever. If we can't supply it, we'll tell you.
Produced to research-grade standards with quality at the core.
Every mechanism of action is explained against peer-reviewed literature.
All compounds sourced from verified, documented suppliers.
Our medical professionals answer questions directly—just get in touch.
Before anything makes it into our
selection, we ask the same questions:
Is the mechanism of action well understood?
Is there a substantive body of peer reviewed research behind it?
Does it sit meaningfully within the science of biological optimization, cellular health, or metabolic function?
If the answer to any of those is no, it
doesn't make the cut.
What We Supply
We supply compounds at the forefront of bio-optimization research—spanning cellular energy metabolism, tissue repair, body composition, and metabolic function.
The line is deliberately selective, built around the strength of the science rather than the size of the market. Each compound must reflect a well-understood mechanism of action and a meaningful body of peer-reviewed research before we stock it.
And as bio-optimization science moves forward, we move with it—adding compounds that meet that bar and removing anything that no longer does.
Some of the most active work in the life sciences right now sits in metabolic signaling: the receptor systems that govern how cells sense and respond to hormonal cues. Much of it centers on the G-protein-coupled receptors involved in glucose-dependent insulin signaling and energy homeostasis, and on the growing interest in agonists that act across more than one of these pathways at once.
This is the biology of how cells generate and manage energy: mitochondrial function, the electron transport chain, and the redox cofactors and enzymes that keep ATP production running. It connects directly to genome maintenance, since enzyme families such as the sirtuins and PARPs link a cell's energy status to its capacity for DNA repair. Research here works to map how those pathways are regulated and how their efficiency shifts under metabolic stress.
Tissue repair is a tightly choreographed process fibroblasts laying down extracellular matrix, satellite cells driving muscle regeneration, and signaling cascades coordinating inflammation, remodeling, and resolution. Research in this area focuses on the molecular signals that govern each phase: which pathways initiate repair, which ones rebuild connective tissue and collagen, and how the whole sequence is regulated from injury through to remodeling.
Skin research draws on the same regenerative biology concentrated in the dermis. The focus sits on dermal fibroblast activity, the synthesis of collagen and other extracellular matrix proteins, and the copper-dependent enzymatic processes—lysyl oxidase, among them—that cross-link and stabilize that matrix. At this level, cellular renewal is as much about matrix architecture as it is about the cells themselves.
